| 摘要 |
PURPOSE: A pharmaceutical formulation for treating cardiovascular diseases is provided to uniformly maintain blood pressure and use for suppressing blood pressure when a hypertension patient sleeps. CONSTITUTION: A pharmaceutical formulation for treating cardiovascular disease contains immediate release compartment and sustained release compartment. The immediate release compartment contains an olmesartan as a pharmacologically active ingredient, its pharmaceutically acceptable salt or its prodrug. The sustained release compartment contains an amlodipine as a pharmacologically active ingredient, or its pharmaceutically acceptable salt.
|
